Mechanistic models enable the rational use of in vitro drug-target binding kinetics for better drug effects in patientsde Witte, Wilhelmus EA, et al. Expert Opinion on Drug Discovery (2015): 1-19.
Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein.Cullen KS, Al-Oanzi ZH, O'Harte FP, Agius L, Arden C. - Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK. Department of Laboratory Medicine, Al-Jouf University, Sakaka, Saudi Arabia. The Saad Centre for Pharmacy & Diabetes, School of Biomedical Sciences, University of Ulster, Coler Biochim Biophys Acta. 2014 Jun;1843(6):1123-34.